Neurogene (NGNE) Stock Insights
$481.75M
Market Cap
—
P/E
—
Forward P/E
—
Score
NGNE price $30.49 +3.50 +12.95%
NGNE fair value $104.80. Price $30.49. Price is 71% below fair value.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Calculated with a 10-year free-cash-flow discount. Starting free cash flow 254.46K. Growth 11.32%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 12.00% (beta 2.0). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 15.80M. Net debt -93.95M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the median P/E of the company's industry. That median uses listed stocks worth at least $10 billion with a positive P/E of 100 or below, and the industry needs at least eight of them. Otherwise the sector median is used when that group also has at least eight, then the market median of those large companies. The multiple used is the lower of that median and 1.25 times the stock's own 10-year median P/E, then kept between 8 and 30. If the stock has no 10-year median, the peer median is kept between 8 and 30. Fair value is the average of the cash-flow value and the earnings value when both exist. Card and credit companies use the earnings value only, because changes in customer receivables distort free cash flow. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.
Model uncertainty high for this stock
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-11-12 | — | -1.49 | — | — |
| 2026-08-11 | -1.53 | -1.42 | — | — |
| 2026-05-12 | -1.39 | -1.30 | — | — |
| 2026-03-24 | -1.12 | -1.24 | — | — |
| 2025-11-14 | -0.99 | -1.26 | — | — |
| 2025-08-11 | -1.05 | -1.15 | — | — |
| 2025-05-09 | -1.08 | -1.05 | — | — |
| 2025-03-24 | -0.99 | -1.04 | — | — |
| 2024-11-18 | -1.19 | -1.22 | — | — |
| 2024-08-09 | -1.09 | -1.05 | 925.00K | — |
| 2024-05-09 | -1.00 | -1.13 | — | — |
| 2024-03-18 | -1.51 | -1.17 | — | — |
| 2023-11-14 | -2.47 | -0.60 | — | — |
| 2023-08-10 | -0.21 | -0.80 | — | — |
| 2023-05-08 | -5.20 | -4.40 | — | — |
| 2023-03-20 | -4.80 | -3.80 | — | — |
| 2022-11-14 | -4.80 | -6.09 | — | — |
| 2022-08-09 | -5.60 | -6.00 | — | — |
| 2022-05-09 | -5.60 | -5.96 | — | — |
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-09-22 | McMinn Rachel | Buy | 756 | $25.32 | 19.14K |
| 2026-09-22 | McMinn Rachel | Sell | 756 | $25.32 | 19.14K |
| 2026-07-07 | Cvijic Christine Mikail | Sell | 4.20K | $36.13 | 151.76K |
| 2026-07-06 | Cvijic Christine Mikail | Sell | 600 | $36.02 | 21.61K |
| 2026-07-02 | Cvijic Christine Mikail | Sell | 2.53K | $34.58 | 87.52K |
| 2026-07-02 | Cvijic Christine Mikail | Sell | 1.53K | $35.23 | 53.90K |
| 2026-07-01 | Cvijic Christine Mikail | Sell | 739 | $34.06 | 25.17K |
| 2026-05-06 | Cvijic Christine Mikail | Sell | 4.80K | $30.07 | 144.35K |
| 2026-05-06 | Cvijic Christine Mikail | Sell | 4.80K | $32.44 | 155.69K |
| 2026-05-05 | Shafer Christina | Buy | 120.00K | $28.94 | 3.47M |
| 2026-04-20 | Shafer Christina | Other | 0 | — | — |
| 2026-03-26 | Cvijic Christine Mikail | Sell | 2.56K | $21.62 | 55.32K |
| 2026-03-26 | McMinn Rachel | Sell | 3.35K | $22.07 | 74.00K |
| 2026-03-26 | Jordan Julie | Sell | 828 | $21.89 | 18.13K |
| 2026-03-13 | Cobb Stuart | Sell | 3.99K | $20.41 | 81.46K |
| 2026-03-13 | Cobb Stuart | Sell | 2.66K | $21.34 | 56.72K |
| 2026-03-13 | Cobb Stuart | Sell | 148 | $22.08 | 3.27K |
| 2026-03-13 | Cvijic Christine Mikail | Sell | 2.39K | $20.42 | 48.75K |
| 2026-03-13 | Cvijic Christine Mikail | Sell | 1.40K | $21.25 | 29.64K |
| 2026-03-13 | Cvijic Christine Mikail | Sell | 263 | $22.02 | 5.79K |
| 2026-02-27 | Cvijic Christine Mikail | Sell | 4.80K | $25.11 | 120.53K |
| 2026-02-20 | Cobb Stuart | Buy | 16.50K | — | — |
| 2026-02-20 | Jordan Julie | Buy | 29.60K | $17.64 | 522.14K |
| 2026-02-20 | Jordan Julie | Buy | 4.90K | — | — |
| 2026-02-20 | Cvijic Christine Mikail | Buy | 131.90K | $17.64 | 2.33M |
| 2026-02-20 | Cvijic Christine Mikail | Buy | 22.00K | — | — |
| 2026-02-20 | McMinn Rachel | Buy | 25.90K | — | — |
| 2026-02-20 | McMinn Rachel | Buy | 155.10K | $17.64 | 2.74M |
| 2026-02-20 | PALEKAR ROHAN | Buy | 12.05K | $17.64 | 212.56K |
| 2026-02-20 | BAFFI ROBERT | Buy | 12.05K | $17.64 | 212.56K |
| 2026-02-20 | Noonberg Sarah B. | Buy | 12.05K | $17.64 | 212.56K |
| 2026-02-20 | Freedland Cory S. | Buy | 12.05K | $17.64 | 212.56K |
| 2026-02-20 | Woods Keith | Buy | 12.05K | $17.64 | 212.56K |
| 2025-06-12 | Woods Keith | Buy | 12.05K | $20.40 | 245.82K |
| 2025-06-12 | BAFFI ROBERT | Buy | 12.05K | $20.40 | 245.82K |
| 2025-06-12 | Woods Robert Keith | Buy | 12.05K | $20.40 | 245.82K |
| 2025-06-12 | PALEKAR ROHAN | Buy | 12.05K | $20.40 | 245.82K |
| 2025-06-12 | Freedland Cory S. | Buy | 12.05K | $20.40 | 245.82K |
| 2025-06-12 | Noonberg Sarah B. | Buy | 12.05K | $20.40 | 245.82K |
| 2025-05-14 | Cobb Stuart | Sell | 6.80K | $15.15 | 103.00K |
| 2025-03-26 | Cobb Stuart | Buy | 42.90K | $16.14 | 692.41K |
| 2025-03-26 | Cobb Stuart | Buy | 7.20K | — | — |
| 2025-03-26 | Cvijic Christine Mikail | Buy | 122.00K | $16.14 | 1.97M |
| 2025-03-26 | Cvijic Christine Mikail | Buy | 20.30K | — | — |
| 2025-03-26 | Jordan Julie | Buy | 50.30K | $16.14 | 811.84K |
| 2025-03-26 | Jordan Julie | Buy | 8.40K | — | — |
| 2025-03-26 | McMinn Rachel | Buy | 23.90K | — | — |
| 2025-03-26 | McMinn Rachel | Buy | 143.50K | $16.14 | 2.32M |
| 2025-03-13 | Cvijic Christine Mikail | Sell | 4.50K | $16.94 | 76.25K |
| 2024-11-26 | Samsara BioCapital GP, LLC | Buy | 2.00K | $27.50 | 55.00K |
| 2024-11-26 | Samsara BioCapital GP, LLC | Buy | 15.22K | $26.73 | 406.80K |
| 2024-11-26 | Samsara BioCapital GP, LLC | Buy | 10.80K | $26.01 | 280.99K |
| 2024-11-26 | Samsara BioCapital GP, LLC | Buy | 20.75K | $24.91 | 516.83K |
| 2024-11-25 | Samsara BioCapital GP, LLC | Other | 0 | — | — |
| 2024-11-25 | Samsara BioCapital GP, LLC | Other | 67.07K | — | — |
| 2024-11-25 | Samsara BioCapital GP, LLC | Other | 20.00K | $0.00 | 20 |
| 2024-11-22 | Cvijic Christine Mikail | Buy | 24.00K | $20.48 | 491.40K |
| 2024-11-22 | McMinn Rachel | Buy | 47.50K | $20.40 | 969.00K |
| 2024-06-14 | Woods Keith | Buy | 7.70K | $42.59 | 327.94K |
| 2024-06-14 | Woods Robert Keith | Buy | 7.70K | $42.59 | 327.94K |
| 2024-06-14 | PALEKAR ROHAN | Buy | 7.70K | $42.59 | 327.94K |
| 2024-06-14 | BAFFI ROBERT | Buy | 7.70K | $42.59 | 327.94K |
| 2024-06-14 | Noonberg Sarah B. | Buy | 7.70K | $42.59 | 327.94K |
| 2024-06-14 | Freedland Cory S. | Buy | 7.70K | $42.59 | 327.94K |
| 2024-03-13 | McMinn Rachel | Buy | 93.28K | $36.06 | 3.36M |
| 2024-03-13 | Cvijic Christine Mikail | Buy | 53.90K | $36.06 | 1.94M |
| 2024-03-13 | Cvijic Christine Mikail | Buy | 31.90K | — | — |
| 2024-03-13 | Cobb Stuart | Buy | 34.45K | $36.06 | 1.24M |
| 2024-03-13 | Cobb Stuart | Buy | 20.39K | — | — |
| 2024-01-16 | Woods Keith | Buy | 15.40K | $32.30 | 497.42K |
| 2023-12-18 | Woods Keith | Other | 0 | — | — |
| 2023-12-18 | BAKER BROS. ADVISORS LP | Buy | 1.15M | — | — |
| 2023-12-18 | BAKER BROS. ADVISORS LP | Buy | 221.56K | — | — |
| 2023-12-18 | BAKER BROS. ADVISORS LP | Buy | 310.13K | — | — |
| 2023-12-18 | BAKER BROS. ADVISORS LP | Buy | 973.29K | — | — |
| 2023-12-18 | BAKER BROS. ADVISORS LP | Buy | 93.48K | — | — |
| 2023-12-18 | BAKER BROS. ADVISORS LP | Buy | 20.56K | — | — |
| 2023-12-18 | BAKER BROS. ADVISORS LP | Buy | 28.78K | — | — |
| 2023-12-18 | BAKER BROS. ADVISORS LP | Buy | 78.33K | — | — |
Latest filed quarter: Q2 2026.
Institutions holding: 117, holders +16 vs prior quarter. Ownership 76.92%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| SAMSARA BIOCAPITAL, LLC | 1.72M | 0 | 0.00% | 54.00M |
| CASDIN CAPITAL, LLC | 1.55M | 125.00K | +8.80% | 48.60M |
| REDMILE GROUP, LLC | 1.41M | -47.40K | -3.25% | 44.41M |
| RTW INVESTMENTS, LP | 1.36M | 0 | 0.00% | 42.85M |
| ECOR1 CAPITAL, LLC | 1.27M | 0 | 0.00% | 39.98M |
| BLACKROCK, INC. | 1.06M | 52.91K | +5.26% | 33.27M |
| BAKER BROS. ADVISORS LP | 991.69K | 0 | 0.00% | 31.19M |
| BALYASNY ASSET MANAGEMENT L.P. | 818.71K | 100.32K | +13.96% | 25.75M |
| TRAILS EDGE CAPITAL PARTNERS, LP | 714.88K | -67.90K | -8.67% | 22.48M |
| TORONTO DOMINION BANK | 681.34K | 0 | 0.00% | 21.43M |
| VANGUARD CAPITAL MANAGEMENT LLC | 536.52K | 21.80K | +4.23% | 16.87M |
| JENNISON ASSOCIATES LLC | 518.58K | -9.10K | -1.73% | 16.31M |
| CITADEL ADVISORS LLC | 408.98K | 397.88K | +3584.52% | 12.86M |
| GREAT POINT PARTNERS LLC | 352.18K | -147.82K | -29.56% | 11.08M |
| ARROWMARK COLORADO HOLDINGS LLC | 342.45K | -182.34K | -34.75% | 10.77M |
| FMR LLC | 295.56K | -87.09K | -22.76% | 9.30M |
| GEODE CAPITAL MANAGEMENT, LLC | 293.18K | 14.18K | +5.08% | 9.22M |
| STATE STREET CORP | 224.32K | -88.68K | -28.33% | 7.05M |
| FRANKLIN TEMPLETON INC | 204.28K | 204.28K | New | 6.42M |
| MORGAN STANLEY | 191.72K | -93.52K | -32.78% | 6.03M |
| UBS GROUP AG | 171.29K | -14.39K | -7.75% | 5.39M |
| BLAIR WILLIAM & CO/IL | 146.91K | -21.31K | -12.67% | 4.62M |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 143.53K | 110.76K | +338.05% | 4.51M |
| POINT72 ASSET MANAGEMENT, L.P. | 141.92K | 141.92K | New | 4.46M |
| MOORE CAPITAL MANAGEMENT, LP | 141.64K | 141.64K | New | 4.45M |
Insights · Dividends · Forecast · Financials · Learn
$481.75M
Market Cap
—
P/E
—
Forward P/E
—
Score